Patent ID: 11918575
Assignee: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. The process as claimed in claim 3, wherein the one or more additional antibacterial drugs are anti-tuberculosis drugs selected from:
agents known to interfere with the respiratory chain of Mycobacterium tuberculosis; 
antibacterial agents that target the electon transport chain;
mycobacterial agents selected from rifampicin; isoniazid; pyrazinamide; amikacin;
ethionamide; ethambutol; streptomycin; para-aminosalicylic acid; cycloserine;
capreomycin; kanamycin; thioacetazone; PA-824; delamanid; quinolones;
fluoroquinolones; macrolides; rifamycins; rifabutin; rifapentin; delanamid; pretonamid, or a combination thereof.